Abstract
Phospholamban (PLN) is a dynamic single-pass membrane protein that inhibits the flow of Ca2+ ions into the sarcoplasmic reticulum (SR) of heart muscle by directly binding to and inhibiting the SR Ca2+ATPase (SERCA). The PLN monomer is the functionally active form that exists in equilibrium between ordered (T state) and disordered (R state) states. While the T state has been fully characterized using a hybrid solution/solid-state NMR approach, the R state structure has not been fully portrayed. It has, however, been detected by both NMR and EPR experiments in detergent micelles and lipid bilayers. In this work, we quantitatively probe the μsec to msec dynamics of the PLN excited states by observing the T state in DPC micelles using CPMG relaxation dispersion NMR spectroscopy under functional conditions for SERCA. The 15N backbone and 13Cδ1 Ile-methyl dispersion curves were fit using a two-state equilibrium model, and indicate that residues within domain Ia (residues 1–16), the loop (17–22), and domain Ib (23–30) of PLN undergo μs-ms dynamics (kex = 6100 ± 800 s−1 at 17 °C). We measured kex at additional temperatures, which allowed for a calculation of activation energy equal to ~5 kcal/mol. This energy barrier probably does not correspond to the detachment of the amphipathic domain Ia, but rather energy needed to unwind domain Ib on the membrane surface, likely an important mechanism by which PLN converts between high and low affinity states for its binding partners.
Keywords: Phospholamban, NMR, Protein Dynamics, Relaxation Dispersion, Membrane Proteins, Ca2+-ATPase, SERCA, solution NMR
Introduction
Regulation of heart muscle contractility is a dynamic event requiring molecular control over the concentration of intracellular calcium. This process is primarily carried out by the ryanodine receptors, which release Ca2+ from the sarcoplasmic reticulum (SR), and Ca2+-ATPase (SERCA), which pumps Ca2+ into the SR. SERCA is inhibited by an integral membrane protein phospholamban (PLN) in cardiac muscle [1]. Phosphorylation at Ser16 and/or Thr17 relieves inhibition, allowing for full viability of SERCA [2]. It has been shown that phosphorylated Ser16 PLN (pS16-PLN) causes a partial order-to-disorder transition resulting in an alteration of all four of the PLN dynamic domains: Ia (residues 1–16), loop (residues 17–22), Ib (residues 23–30), and II (residues 31–52) [3].
In the absence of SERCA, PLN exists in equilibrium between a dynamically ordered T state (Figure 1, PDB 2KB7 [4]) and a dynamically disordered R state [5;6]. The T state is the most populated in both lipid bilayers and detergent micelles [7;8], having a population of 84% measured by EPR in DOPC/DOPE lipid bilayers [9]. While the T and R states are both able to bind SERCA [10], the R state likely has a higher affinity for the enzyme [11;12], as well as being necessary for recognition of its other binding partners, e.g., protein kinase A (PKA), Ca2+/calmodulin-dependent kinase II (CAMKII), and A-kinase anchoring protein (AKAP) [13]. Understanding the dynamics for this T to R state equilibrium is necessary to rationalizing how these states play a role in SERCA regulation and thus Ca2+ concentrations within the cell.
NMR spin relaxation measurements give insight into local and global dynamics of proteins over a wide range of timescales (psec to sec) under native-like conditions [14–18]. An important dynamic timescale that has been correlated with catalytic activity is μsec to msec motion [19–24]. To probe this dynamics, the use Carr-Purcell-Meiboom-Gill (CPMG) and spin-locking relaxation dispersion experiments (T1ρ) are valuable [25–28]. In our previous work, we quantitatively characterized the dynamics of PLN on the psec to nsec timescale and qualitatively showed PLN to exhibit slow dynamics [3;6]. In this study, we illustrate the kinetic and thermodynamic parameters for the PLN excited states by quantifying slow μsec to msec dynamics using backbone 15N and Ile-methyl group 13Cδ1 CPMG relaxation dispersion measurements.
Material and Methods
Protein Production
A fully functional monomeric mutant of PLN (C36A, C41F, C46A, AFA-PLN) was expressed [U-15N] and [13Cδ1-Ile] using 15NH4Cl and 2-ketobutyric acid-4-13C,3,3-d2 (Isotec-Sigma/Aldrich), and purified as previously described [29;30]. After HPLC purification, the protein was lyophilized with the subsequent powder stored at −20 °C until sample preparation.
Sample Preparation
AFA-PLN samples were dissolved to a concentration of 1 mM in 300 mM DPC, 120 mM NaCl, 20 mM sodium phosphate (pH 6.0), and 0.01% NaN3 as previously used by our laboratory in several papers [3;30;31]. These samples were stable over several weeks over the temperature range used in these studies.
NMR Spectroscopy
Spin relaxation experiments were performed using two AFA-PLN samples: 1) [U-15N], [13Cδ1-Ile] and 2) [U-15N]. Single quantum 15N CPMG experiments with temperature compensation were carried out at B0 = 14.1 and 18.7 T using relaxation compensated HSQC [32] and TROSY pulse sequences [33;34] with constant time delays of 20 and 40 msec, respectively. The 20 msec time was needed at 12 °C for the [U-15N] sample to increase signal to noise. The time spacing between the 180° pulse centers is equal to 2τcp, which is expressed as a frequency (νCPMG) equal to 1/(4τcp). For the first sample, 2D datasets were acquired for νCPMG = 50(x2), 100, 150, 200, 250, 300, 350, 400(x2), 450, 500, 600, 700, 800, 900, 1000(x2) Hz at B0 = 14.1 and 18.7 T (at 17 °C). For the second sample, spectra were acquired in duplicate for νCPMG = 50, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, and 1000 Hz at B0 = 14.1 T, and in duplicate for νCPMG = 50, 100, 200, 300, 400, 500, 600, 800, and 1000 Hz at B0 = 18.7 T (at 17 °C). In order to assess the backbone exchange kinetics as a function of temperature, we acquired CPMG dispersion data at 12, 17, and 22 °C using a constant time delay of 20 msec in triplicate using νCPMG = 100, 200, 300, 500, 700, and 1000 Hz at both B0 = 14.1 and 18.7 T (see Supporting Information Figure 1).
The 13C multiple quantum relaxation experiments [35] were all performed at B0 = 14.1 T with a constant time delay of 40 msec using νCPMG values at the following temperatures: 5 °C [50(x2), 100, 150, 700, 800, 900, 1000(x2)], 10 °C, 20 °C, and 37 °C all with [50, 100(x2), 150, 200, 250, 300(x2), 350, 400, 450, 500, 600, 700, 800(x2), 900, 1000 Hz]. Reference spectra were acquired with no constant time delay for each of the experiments.
Room temperature triple-axis gradient HCN Varian probes were used for all measurements, except one set of data using a [U-15N] sample at B0 = 18.7 T, in which a Varian cold-probe was used. Due to a slight detuning of the 15N channel on the cold-probe at larger values of νCPMG, we applied a linear correction to those residues that showed dispersion (see Supporting Information Figure 2). This correction was calculated from residues that did not show an exchange contribution to relaxation on the room temperature probes, and was relatively minor (~2 Hz difference in R2eff for νCPMG = 50 Hz and νCPMG = 1000 Hz). R2eff was calculated using the following relationship: , where I(νCPMG) is the intensity for a given value of νCPMG, I0 is the intensity of the reference spectrum, and T is the constant time delay. All errors reported in the figures are standard deviations from multiple experiments, or in cases where no duplicate or triplicate existed, the average of the standard deviation for points that were repeated.
A 100% methanol standard was used to calibrate the temperature on the spectrometers. All of the experiments were acquired with Varian spectrometers (VNMRS for B0 = 14.1 T and INOVA for B0 = 18.7 T), with the data processed in NMRPipe [36] and peak-picked in Sparky [37].
Results
Our previous data on the μsec-msec dynamics on AFA-PLN were acquired at B0 = 18.7 T and a temperature of 37 °C [3;6]. While these measurements qualitatively showed PLN to display slow dynamics, the ΔR2 dispersions were rather small. In the new experiments, we first performed dispersion measurements at B0 = 14.1 T and 37 °C, but found all residues to show dispersions < 2 Hz. As the temperature was decreased to 22 °C and below, the dispersions became substantial for a number of residues. Interestingly, as the temperature was decreased from 37 °C, Thr17 and Ala24 became significantly broadened, which alone indicates a relaxation contribution from chemical exchange (Rex), as anticipated by both NMR [3;6] and EPR data [5]. To assess kex as a function of temperature (12, 17, and 22 °C) we acquired 15N dispersion curves at B0 = 14.1 and 18.7 T. The data are shown in Figure 2 and Supporting Information Figure 1, where the error bars reflect the standard deviation between two (Figure 2) or three identical experiments (Supporting Information Figure 1) for each value of νCPMG collected in an interleaved manner.
A total of seven residues (Ser16, Thr17, Gln22, Gln23, Arg25, Gln26, and Asn27) display dispersion curves with ΔR2 > 2 Hz (i.e., dispersion), where ΔR2 = R2eff(νCPMG = 50 Hz) − R2eff(νCPMG = 1000 Hz). These residues are located within three domains of PLN (the loop and domains Ia and Ib). From the data shown in Figure 2, ΔR2 for B0 = 14.1 and 18.7 T change by the expected quadratic scaling (~1.78) for fast exchange (Δω2; see below). Therefore, all residues were fit to a two-site fast exchange model (Eqn 1) to extract kinetic information from the dispersion curves [38].
(1) |
φex = pApBΔω2, pA and pB are the populations of the two states, Δω is the chemical shift difference between states A and B, kex is the exchange rate (sum of forward and reverse rate constants for the A ⇔ B equilibrium), and R2 is the intrinsic relaxation rate (assumed to be the same for states A and B). A least-squares fit to Eqn 1 was carried out in Mathematica to extract kex, R2, and φex for individual residues (at both magnetic fields) as well as a global fit [39]. The global fit was performed by simultaneously minimizing kex for all residues at both magnetic fields (Table I). Importantly, the global kex values and the average values are in good agreement. The global kex values are 6000 ± 600 (12 °C), 6100 ± 800 s−1 (17 °C), and 8100 ± 700 for Ser16, Thr 17, Gln22, Gln23, Arg25, Gln26, and Asn27. The error bars reflect an 85% confidence interval.
Table I.
kex (s−1) | ||
---|---|---|
12 °C | 17 °C | 22 °C |
6000 ± 600 | 6100 ± 800 | 8100 ± 700 |
As shown in Supporting Information Figure 1, the HSQC-CPMG pulse sequence from Loria et al. [32] gave field-dependent R2 values for all the residues, even those that did not experience chemical exchange (data not shown). In the absence of a correction factor, the data fitting gave inconsistent values of kex relative to those determined using the TROSY CPMG sequence (no correction was needed for these experiments) [33;34]. For this reason, a correction factor was applied to R2 for all residues experiencing chemical exchange in Eqn 1 (a global fit).
From the exchange rates reported in Table I, an Arrhenius plot was constructed (Figure 3) to determine the activation energy for the T state to an excited state. From the plot, we calculated an activation energy of ~5 kcal/mol.
In addition to the backbone 15N CPMG dispersion curves, we also carried out dispersion analysis for Ile-methyl groups in AFA-PLN. Since the methyl groups are less sensitive to helical folding and more to electrostatic environment (hydrophobic packing, solvent structure, etc.), they are a better probe to test the solvent accessibility of PLN domains Ia and Ib. Within the Ile 13Cδ1 spectra, the residues that gave dispersion were Ile12 and Ile18 (out of the 8 Ile methyl groups within PLN). Similar to the results for the backbone 15N sites, Ile12 and Ile18 did not show significant dispersion at 37 °C at B0 = 14.1 T. Upon decreasing the temperature, the methyl groups became quite sensitive to the dynamics, showing substantial dispersion (Figure 4). Unfortunately, the Ile12 13Cδ1 resonance became substantially broadened at temperatures below 20 °C, leading to noisy dispersion data.
Discussion
The presence of the T and R states has been shown to be critical in the regulation of SERCA [10;12]. While the T state appears to be an inhibitory form of SERCA, the R state seems more important in the relief of SERCA regulation, as shown by Thomas and co-workers using an N-terminal lipid anchored PLN molecule (~100% T state) [10]. This knowledge encouraged the design of PLN mutants that might be able to lower the activation energy barrier to the R state, or simply increase the population of the R state, i.e., better mimic the R state [31]. This research is ongoing, and continues to be a promising path toward the design of therapeutic mutants that not only might overcome the effects of endogenous loss or gain-of-function PLN mutants, but also assist in the recovery of damaged heart muscle tissue.
Previously, our analysis of T1, T2, and heteronuclear NOE experiments for monomeric PLN showed the existence of two dynamically dissimilar domains within the single α-helix comprised of residues 22–52 [6]. The primary sequences of PLN agree well with this expected hydrophobic mismatch. Domain Ib is comprised of several hydrophilic and charged amino acids (Gln23, Ala24, Arg25, Gln26, Asn27, Leu28, Gln29, Asn30), while domain II is mainly comprised of hydrophobic amino acid residues (Leu, Ile, Val, and Phe). While the first structure reported by our laboratory in detergent micelles did not show the depth of insertion with respect to the membrane [7], our new structure exemplifies the dissimilarity of domains Ib and II in terms of dynamics and depth of membrane insertion (Figure 1) [4;40]. The solvent exchange data also agrees with this structure, as domain Ib exchanges readily with H2O, while domain II does not [7]. In fact, in perdeuterated growths of PLN [30], the majority of residues within domain II have attached deuterons to the amide nitrogen throughout the protein purification (3–4 days). Only upon unfolding of the protein and elevated temperature do these sites exchange with H2O.
Domain Ib (residues 23–30) is well-known to be important in the regulation of SERCA [41]. Alanine-scanning mutagenesis indicates that most mutations in this region give rise to PLN mutants with gain-of-function, i.e., more inhibition [41]. In this work, we quantitatively assessed the chemical exchange of the T state of PLN, through the use of CPMG relaxation dispersion measurements. Our results indicate that several residues in domain Ib show dynamics in the μsec to msec timescale. However, the observed exchange rates reported for PLN in Table I are not likely a simple exchange between T and R states, at least not for both amide backbone sites and side chain methyl groups. The reason is that in the methyl group spectrum of AFA-PLN, we detected both the T and R states for residues in domain Ia (i.e., slow exchange) [42]. Since we observed dispersion for Ile12 and Ile18 methyl groups at the 13Cδ position (Figure 4), this means that the T state is in fast chemical exchange with another state. On the other hand, the backbone amide sites of the R state are not in slow exchange, which reflects the fact that the chemical shift differences (Δω) are smaller than for the methyl groups [11;12] Figure 5 shows an unfolding model where we suggest an intermediate in the energy landscape toward the full R state. The first step depicts a partial unwinding of domains Ia and Ib (kex in fast chemical exchange) followed by a partial unwinding and detachment of domain Ia from the membrane (kex in slow chemical exchange [42]). This mechanism is similar to proposed models for the folding and unfolding of amphipathic antimicrobial peptides and proteins [43]. Therefore, assuming that domain Ib is similar in structure for the intermediate and final R state, the chemical exchange kinetics reported are reflective of the T to R state transition for backbone atoms, which would have an activation energy barrier of ~5 kcal/mol as measured by our CPMG experiments. Although this needs to be further investigated, domain Ib unwinding is supported by a model of PLN bound to SERCA (model by MacLennan and Toyoshima [44] as well as the hypothesis that PLN needs to extend and potentially be pulled up from the membrane to interact with SERCA ([10]). The reported activation energy also is quite similar to those reported for amphipathic membrane peptides and proteins [43; 45–50].
These new data further elucidate the dynamic picture of PLN, emphasizing the role of the loop and domains Ia and Ib in the partial unfolding process that may be needed to enable PLN to mold into the SERCA enzyme. The conformational dynamics of PLN is preserved in the presence of SERCA, where both T and R states have been detected by EPR [10]. Therefore, we propose that the inhibitory process occurs through a shift of the conformational equilibrium of T and R PLN states rather than through discrete (static) conformational states (free and bound).
Importantly, the conformational equilibrium of PLN between T and R states is tunable [31]. Ser16 phosphorylation of PLN, targeted mutations in the dynamic loop [31], and lipid membrane composition [51] have direct repercussions in SERCA affinity for calcium. In our recent paper [31], we used this information to design loss-of-function mutants of PLN to be tested in gene therapy, and proposed that new mutants must be promoted to the excited state (R state) for binding SERCA more effectively. In our previous work, however, we limited our functional manipulation and the rational mutagenesis to the dynamic loop of PLN. These new dynamics data implicate several residues in domains Ia and Ib that need to be incorporated to our existing knowledge database in order to design other PLN mutants that are more effective (better binder and loss-of-function) than the P21G mutant previously reported [31].
These studies stress the importance of dynamics in the functional characterization of the ground and excited states of small regulatory integral membrane proteins, enabling the progression of structural biophysics from understanding the biological phenomena to controlling the function.
Supplementary Material
ABBREVIATIONS
- PLN
Phospholamban
- SERCA
sarco(endo)plasmic reticulum Ca-ATPase
- CPMG
Carr-Purcell-Meiboom-Gill
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol. 2003;4:566–577. doi: 10.1038/nrm1151. [DOI] [PubMed] [Google Scholar]
- 2.Wegener AD, Simmerman HK, Lindemann JP, Jones LR. Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation. J.Biol.Chem. 1989;264:11468–11474. [PubMed] [Google Scholar]
- 3.Metcalfe EE, Traaseth NJ, Veglia G. Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban. Biochemistry. 2005;44:4386–4396. doi: 10.1021/bi047571e. [DOI] [PubMed] [Google Scholar]
- 4.Traaseth NJ, Shi L, Verardi R, Mullen D, Barany G, Veglia G. Determination of Membrane Protein Structure and Topology Using a Hybrid Solution and Solid-State NMR approach. Proc Natl Acad Sci. 2009;106:10165–10170. doi: 10.1073/pnas.0904290106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Karim CB, Kirby TL, Zhang Z, Nesmelov Y, Thomas DD. Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone. Proc Natl Acad Sci U S A. 2004;101:14437–14442. doi: 10.1073/pnas.0402801101. Epub 2004 Sep 24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Metcalfe EE, Zamoon J, Thomas DD, Veglia G. 1H/15N Heteronuclear NMR Spectroscopy Shows Four Dynamic Domains for Phospholamban Reconstituted in Dodecylphosphocholine Micelles. Biophysical Journal. 2004;87:1–10. doi: 10.1529/biophysj.103.038844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zamoon J, Mascioni A, Thomas DD, Veglia G. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys J. 2003;85:2589–2598. doi: 10.1016/s0006-3495(03)74681-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Traaseth NJ, Buffy JJ, Zamoon J, Veglia G. Structural dynamics and topology of phospholamban in oriented lipid bilayers using multidimensional solid-state NMR. Biochemistry. 2006;45:13827–13834. doi: 10.1021/bi0607610. [DOI] [PubMed] [Google Scholar]
- 9.Nesmelov YE, Karim CB, Song L, Fajer PG, Thomas DD. Rotational dynamics of phospholamban determined by multifrequency electron paramagnetic resonance. Biophys.J. 2007;93:2805–2812. doi: 10.1529/biophysj.107.108910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Karim CB, Zhang Z, Howard EC, Torgersen KD, Thomas DD. Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. J.Mol.Biol. 2006;358:1032–1040. doi: 10.1016/j.jmb.2006.02.051. [DOI] [PubMed] [Google Scholar]
- 11.Traaseth NJ, Thomas DD, Veglia G. Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca(2+)-ATPase complex. J.Mol.Biol. 2006;358:1041–1050. doi: 10.1016/j.jmb.2006.02.047. [DOI] [PubMed] [Google Scholar]
- 12.Zamoon J, Nitu F, Karim C, Thomas DD, Veglia G. Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation. Proc Natl Acad Sci U S A. 2005;102:4747–4752. doi: 10.1073/pnas.0406039102. Epub 2005 Mar 21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Traaseth NJ, Ha KN, Verardi R, Shi L, Buffy JJ, Masterson LR, Veglia G. Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase. Biochemistry. 2008;47:3–13. doi: 10.1021/bi701668v. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Palmer AG, 3rd, Kroenke CD, Loria JP. Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules. Methods Enzymol. 2001;339:204–238. doi: 10.1016/s0076-6879(01)39315-1. [DOI] [PubMed] [Google Scholar]
- 15.Kay LE. Protein dynamics from NMR. Nat.Struct.Biol. 1998;(5 Suppl):513–517. doi: 10.1038/755. [DOI] [PubMed] [Google Scholar]
- 16.Torchia DA. Solid state NMR studies of protein internal dynamics. Annu.Rev.Biophys.Bioeng. 1984;13:125–144. doi: 10.1146/annurev.bb.13.060184.001013. [DOI] [PubMed] [Google Scholar]
- 17.Boehr DD, Dyson HJ, Wright PE. An NMR perspective on enzyme dynamics. Chem.Rev. 2006;106:3055–3079. doi: 10.1021/cr050312q. [DOI] [PubMed] [Google Scholar]
- 18.Peng JW, Wagner G. Investigation of protein motions via relaxation measurements. Methods Enzymol. 1994;239:563–596. doi: 10.1016/s0076-6879(94)39022-3. [DOI] [PubMed] [Google Scholar]
- 19.Mulder FA, Mittermaier A, Hon B, Dahlquist FW, Kay LE. Studying excited states of proteins by NMR spectroscopy. Nat.Struct.Biol. 2001;8:932–935. doi: 10.1038/nsb1101-932. [DOI] [PubMed] [Google Scholar]
- 20.Beach H, Cole R, Gill ML, Loria JP. Conservation of mus-ms enzyme motions in the apo- and substrate-mimicked state. J.Am.Chem.Soc. 2005;127:9167–9176. doi: 10.1021/ja0514949. [DOI] [PubMed] [Google Scholar]
- 21.Boehr DD, McElheny D, Dyson HJ, Wright PE. The dynamic energy landscape of dihydrofolate reductase catalysis. Science. 2006;313:1638–1642. doi: 10.1126/science.1130258. [DOI] [PubMed] [Google Scholar]
- 22.Kern E.R DZ. The role of dynamics in allosteric regulation. Curr Opin Struct Biol. 2003;13:748–757. doi: 10.1016/j.sbi.2003.10.008. [DOI] [PubMed] [Google Scholar]
- 23.Grey MJ, Wang C, Palmer AG., 3rd Disulfide bond isomerization in basic pancreatic trypsin inhibitor: multisite chemical exchange quantified by CPMG relaxation dispersion and chemical shift modeling. J.Am.Chem.Soc. 2003;125:14324–14335. doi: 10.1021/ja0367389. [DOI] [PubMed] [Google Scholar]
- 24.Eisenmesser EZ, Bosco DA, Akke M, Kern D. Enzyme dynamics during catalysis. Science. 2002;295:1520–1523. doi: 10.1126/science.1066176. [DOI] [PubMed] [Google Scholar]
- 25.Korzhnev DM, Kay LE. Probing invisible, low-populated States of protein molecules by relaxation dispersion NMR spectroscopy: an application to protein folding. Acc.Chem.Res. 2008;41:442–451. doi: 10.1021/ar700189y. [DOI] [PubMed] [Google Scholar]
- 26.Palmer AG, 3rd, Massi F. Characterization of the dynamics of biomacromolecules using rotating-frame spin relaxation NMR spectroscopy. Chem.Rev. 2006;106:1700–1719. doi: 10.1021/cr0404287. [DOI] [PubMed] [Google Scholar]
- 27.Loria JP, Berlow RB, Watt ED. Characterization of enzyme motions by solution NMR relaxation dispersion. Acc.Chem.Res. 2008;41:214–221. doi: 10.1021/ar700132n. [DOI] [PubMed] [Google Scholar]
- 28.Akke M. NMR methods for characterizing microsecond to millisecond dynamics in recognition and catalysis. Curr.Opin.Struct.Biol. 2002;12:642–647. doi: 10.1016/s0959-440x(02)00369-x. [DOI] [PubMed] [Google Scholar]
- 29.Buck B, Zamoon J, Kirby TL, DeSilva TM, Karim C, Thomas D, Veglia G. Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies. Protein Expr Purif. 2003;30:253–261. doi: 10.1016/s1046-5928(03)00127-x. [DOI] [PubMed] [Google Scholar]
- 30.Traaseth NJ, Verardi R, Veglia G. Asymmetric methyl group labeling as a probe of membrane protein homo-oligomers by NMR spectroscopy. J.Am.Chem.Soc. 2008;130:2400–2401. doi: 10.1021/ja711499r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ha KN, Traaseth NJ, Verardi R, Zamoon J, Cembran A, Karim CB, Thomas DD, Veglia G. Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics. J.Biol.Chem. 2007;282:37205–37214. doi: 10.1074/jbc.M704056200. [DOI] [PubMed] [Google Scholar]
- 32.Loria JP, Rance M, Palmer AGI. A Relaxation-Compensated Carr-Purcell-Meiboom-Gill Sequence for Characterizing Chemical Exchange by NMR Spectroscopy. J. Am. Chem. Soc. 1999;121:2331–2332. [Google Scholar]
- 33.Loria JP, Rance M, Palmer AG., 3rd A TROSY CPMG sequence for characterizing chemical exchange in large proteins. J.Biomol.NMR. 1999;15:151–155. doi: 10.1023/a:1008355631073. [DOI] [PubMed] [Google Scholar]
- 34.Vallurupalli P, Hansen DF, Stollar E, Meirovitch E, Kay LE. Measurement of bond vector orientations in invisible excited states of proteins. Proc.Natl.Acad.Sci.U.S.A. 2007;104:18473–18477. doi: 10.1073/pnas.0708296104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Korzhnev DM, Kloiber K, Kanelis V, Tugarinov V, Kay LE. Probing slow dynamics in high molecular weight proteins by methyl-TROSY NMR spectroscopy: application to a 723-residue enzyme. J.Am.Chem.Soc. 2004;126:3964–3973. doi: 10.1021/ja039587i. [DOI] [PubMed] [Google Scholar]
- 36.Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
- 37.Goddard TD, Kneller DG. SPARKY 3. University of California: San Francisco; [Google Scholar]
- 38.Luz Z, Meiboom S. Nuclear magnetic resonance study of the protolysis of trimethylammonium ion in aqueous solution-order of the reaction with respect to solvent. J Chem Phys. 1963;39:366–370. [Google Scholar]
- 39.Kovrigin EL, Kempf JG, Grey MJ, Loria JP. Faithful estimation of dynamics parameters from CPMG relaxation dispersion measurements. J.Magn.Reson. 2006;180:93–104. doi: 10.1016/j.jmr.2006.01.010. [DOI] [PubMed] [Google Scholar]
- 40.Shi L, Traaseth NJ, Verardi R, Cembran A, Gao J, Veglia G. A Refinement Protocol to Determine the Structure, Topology, and Depth of Insertion of Membrane Proteins Using Hybrid Solution and Solid-State Restraints. J Biomolec NMR. 2009;44:195–205. doi: 10.1007/s10858-009-9328-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kimura Y, Asahi M, Kurzydlowski K, Tada M, MacLennan DH. Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum. J Biol Chem. 1998;273:14238–14241. doi: 10.1074/jbc.273.23.14238. [DOI] [PubMed] [Google Scholar]
- 42.Gustavsson M, Traaseth NJ, Lockamy E, Thomas DD, Veglia G. Phosphorylation and Pseudo-phosphorylation Shift the Phospholamban Conformational Equilibrium toward Excited States. Submitted. [Google Scholar]
- 43.Almeida PF, Pokorny A. Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry. 2009;48:8083–8093. doi: 10.1021/bi900914g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Toyoshima C, Asahi M, Sugita Y, Khanna R, Tsuda T, MacLennan DH. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc Natl Acad Sci U S A. 2003;100:467–472. doi: 10.1073/pnas.0237326100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hunt JF, Rath P, Rothschild KJ, Engelman DM. Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix. Biochemistry. 1997;36:15177–15192. doi: 10.1021/bi970147b. [DOI] [PubMed] [Google Scholar]
- 46.White SH, Wimley WC. Membrane protein folding and stability: physical principles. Annu.Rev.Biophys.Biomol.Struct. 1999;28:319–365. doi: 10.1146/annurev.biophys.28.1.319. [DOI] [PubMed] [Google Scholar]
- 47.Ladokhin AS, Jayasinghe S, White SH. How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal.Biochem. 2000;285:235–245. doi: 10.1006/abio.2000.4773. [DOI] [PubMed] [Google Scholar]
- 48.Meijberg W, Booth PJ. The activation energy for insertion of transmembrane alpha-helices is dependent on membrane composition. J.Mol.Biol. 2002;319:839–853. doi: 10.1016/S0022-2836(02)00342-X. [DOI] [PubMed] [Google Scholar]
- 49.Fernandez-Vidal M, Jayasinghe S, Ladokhin AS, White SH. Folding amphipathic helices into membranes: amphiphilicity trumps hydrophobicity. J.Mol.Biol. 2007;370:459–470. doi: 10.1016/j.jmb.2007.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Fernandez DI, Gehman JD, Separovic F. Membrane interactions of antimicrobial peptides from Australian frogs. Biochim.Biophys.Acta. 2009;1788:1630–1638. doi: 10.1016/j.bbamem.2008.10.007. [DOI] [PubMed] [Google Scholar]
- 51.Hughes E, Clayton JC, Middleton DA. Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: a new role for phospholipids in the regulation of cardiac calcium cycling? Biochim.Biophys.Acta. 2009;1788:559–566. doi: 10.1016/j.bbamem.2008.10.029. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.